XML 21 R9.htm IDEA: XBRL DOCUMENT v3.22.4

Cash, Cash Equivalents, and Financial Instruments

12 Months Ended

Dec. 31, 2022

Cash and Cash Equivalents [Abstract]

Cash, Cash Equivalents, and Financial Instruments

Note 3 - Cash, Cash Equivalents, and Financial Instruments

The following table shows the Company’s cash, cash equivalents, and marketable investment securities by significant investment category as of December 31, 2022:

 Schedule of Cash, Cash Equivalents, and Marketable Investment Securities

		December 31, 2022
		Adjusted Cost				Allowance for Credit Losses				Total Unrealized Gains / (Losses)				Fair Value				Cash and Cash Equivalents				Marketable Securities
Cash		$	12,834,444			$	-			$	-			$	12,834,444			$	12,834,444			$	-
Level 1:
Money market funds			146,359				-				-				146,359				146,359				-
Subtotal			146,359				-				-				146,359				146,359				-
Level 2:
U.S. treasury securities			67,892,825				-				389,241				68,282,066				9,993,000				58,289,066
Subtotal			67,892,825				-				389,241				68,282,066				9,993,000				58,289,066
Total		$	80,873,628			$	-			$	389,241			$	81,262,869			$	22,973,803			$	58,289,066

Marketable investment securities held as of December 31, 2022 mature over the next 12 months.

X

- References

No definition available.

+ Details

Name:	us-gaap_CashAndCashEquivalentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-URI https://asc.fasb.org/topic&trid=2196928

+ Details

Name:	us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration